Bayesian Capital Management’s Emeren Group SOL Stock Holding History

Bayesian Capital Management’s Portfolio SOL Stock Details SOL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-10,015	Closed	-$30.8K	–	1008
2023 Q3	$30.8K	Buy	+10,015	New	+$34.8K	﹤0.01%	650
2021 Q2	–	Sell	-15,100	Closed	-$186K	–	628
2021 Q1	$186K	Buy	+15,100	New	+$276K	0.04%	470

Other funds holding SOL

SCM

Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Bayesian Capital Management's SOL Position: Q4 2023 in Review

Bayesian Capital Management sold out of Emeren Group (SOL) in Q4 2023, closing a stake of 10,015 shares — an estimated $30.8K sold.

Bayesian Capital Management first reported a position in SOL in Q1 2021 and held it in 2 quarters. The position peaked at $186K in Q1 2021. 64 funds tracked by Wall St. Rank hold SOL as of Q4 2023.

Bayesian Capital Management reported no remaining Emeren Group position as of Q4 2023 after selling out during the quarter.
Bayesian Capital Management sold 10,015 Emeren Group shares in Q4 2023, an estimated $30.8K.
Bayesian Capital Management first reported a position in Emeren Group in Q1 2021 and held it in 2 quarters.
Bayesian Capital Management's Emeren Group position peaked at $186K in Q1 2021.
64 funds tracked by Wall St. Rank held Emeren Group as of Q4 2023.

Based on Bayesian Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.